European Medicines Agency - Regulatory - Regulation of medicines
GENERAL INFORMATION
  Company name: Greenlight Biosciences España, S.L.  
  Address: Carretera Nacional IV, KM 566, 41720 Los Palacios Y Villafranca , Spain  
  Web: https://www.greenlightbiosciences.com/   
  Company creation date: 2022   
  Employees: 133   
  Field of activity: Veterinary   
  Record last updated on: 14/06/2024   
CONTACT DETAILS
  Contact name:    
  Tel:    
  Email:    
COMPANY SECTOR  
(Bio)Pharmaceutical:    
  Early manufacturing/Research&Discovery stage:  
  Development stage:  
  Commercialisation/Marketing stage (EU/Non-EU):  
Medical Device and Technology:    
  Development stage:  
  Commercialisation/Marketing stage (EU/Non-EU):  
PRODUCT INFORMATION  
Medicinal Products      
  Vaccines:  
  Therapeutic medicines:  
  Diagnostic and imaging products:  
  Combined medicinal products and devices:  
Product Development Stages    
Number of Products
  Research/Discovery:
 
  Pharmaceutical development:
 
  Preclinical:
 
  Clinical exploratory:
 
  Clinical confirmatory:
 
  (Pre)registration (EU/Non-EU):
 
  Marketing (EU/Non-EU):
 
SUBSTANCES
Chemical entities    
  Single entities  
  Combinations of single entities  
 Peptides (chemically synthesised)  
Biologically derived proteins and peptides  
  Monoclonal antibodies  
  Recombinant proteins  
  Extracted proteins  
Nucleic Acids (chemically synthesised/biologically derived)  
  RNA  
  DNA  
Polymer (natural and synthetic - excluding peptides, proteins and nucleic acids)  
  Homopolymers  
  Copolymers  
Advanced therapy medicinal products  
  Somatic cell therapy products  
  Tissue engineered products  
  Gene therapy products  
Radionuclides    
Allergens    
Polyclonal immunoglobulins  
Herbal derived complex substances  
Animal derived complex substances  
Other  
SPECIFIC CATEGORIES
  Artificial intelligence, big data, software as medical device, digital health/medicines  
  Biodefense  
  Biosimilars  
  Excipients  
  Foods (functional foods, nutraceuticals)  
  Generics  
  Genetically modified organisms (GMOs)  
  Homeopathics  
  Maximum residue limits (veterinary medicines)  
  Medicines for tropical diseases  
  MUMS (‘Minor Use/Minor species’)/Limited market (veterinary medicines)  
  Nanotechnology (including e.g. microparticles, liposomes, microbeads)  
  New formulations/delivery methods  
  Orphan medicines  
  OTC (over the counter)/non-prescription/self-medication  
  Paediatric medicines  
  Personalised/targeted products, biomarkers, pharmacogenomics, precision medicines, companion diagnostics  
 Stem cells  
  Transgenic technology  
  Other  
THERAPEUTIC AREA
  A Alimentary tract and metabolism  
  B Blood and blood forming organs  
  C Cardiovascular system  
  D Dermatologicals  
  G Genito-urinary system and sex hormones  
  H Systemic hormonal preparations, excluding sex hormones  
  J General anti-infectives for systemic use  
  L Anti-neoplastic and immunomodulating agents  
  M Musculo-skeletal system  
  N Nervous system  
  P Anti-parasitic products, Insecticides, Repellents  
  R Respiratory system  
  S Sensory organs  
  V Various  
 
Back to list